CIK: 0001910456 · Show all filings
Period: Q2 2024 (← Previous) (Next →)
Filing Date: Aug 19, 2024
Total Value ($000): $275,939
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| — | MERUS N V | 1,206,707 | $71,401 | 25.9% | $29.71 | — | — | N5749R100 |
| STOK | STOKE THERAPEUTICS INC | 5,185,191 | $70,052 | 25.4% | $7.94 | +70.1% | — | 86150R107 |
| GHRS | GH RESEARCH PLC | 3,966,726 | $46,252 | 16.8% | $9.14 | +31.4% | — | G3855L106 |
| CCCC | C4 THERAPEUTICS INC | 6,880,527 | $31,788 | 11.5% | $4.53 | +31.7% | — | 12529R107 |
| TCRX | TSCAN THERAPEUTICS INC | 5,224,600 | $30,564 | 11.1% | $2.68 | +194.0% | — | 89854M101 |
| CGEM | CULLINAN THERAPEUTICS INC | 377,323 | $6,581 | 2.4% | $21.29 | 0.0% | — | 230031106 |
| ALLO | ALLOGENE THERAPEUTICS INC | 2,228,295 | $5,192 | 1.9% | $2.95 | 0.0% | — | 019770106 |
| — | LONGBOARD PHARMACEUTICALS IN | 167,317 | $4,523 | 1.6% | $27.03 | — | — | 54300N103 |
| — | PASSAGE BIO INC | 5,057,629 | $4,017 | 1.5% | $1.32 | — | — | 702712100 |
| CABA | CABALETTA BIO INC | 492,103 | $3,681 | 1.3% | $3.64 | +236.6% | — | 12674W109 |
| IBIO | IBIO INC | 240,763 | $508 | 0.2% | $1.26 | +71.0% | — | 451033708 |
| — | BIONOMICS LIMITED | 599,673 | $460 | 0.2% | $2.69 | — | — | 09063M205 |
| — | PIERIS PHARMACEUTICALS INC | 43,499 | $427 | 0.2% | $9.81 | — | — | 720795202 |
| KNSA | KINIKSA PHARMACEUTICALS INTL | 9,500 | $177 | 0.1% | $18.73 | 0.0% | — | G52694109 |
| CNTA | CENTESSA PHARMACEUTICALS PLC | 17,400 | $157 | 0.1% | $11.30 | — | — | 152309100 |
| KRRO | KORRO BIO INC | 3,800 | $129 | 0.0% | $55.25 | 0.0% | — | 500946108 |
| VYNE | VYNE THERAPEUTICS INC | 16,194 | $32 | 0.0% | $2.49 | 0.0% | — | 92941V308 |